Pathological predictors for lymph node metastasis in T1 colorectal cancer

Area of Science:

• Oncology
• Pathology
• Gastroenterology

Background:

• T1 colorectal cancer represents early-stage disease.
• Accurate prediction of lymph node metastasis is crucial for treatment planning and prognosis.
• Identifying reliable pathological predictors is essential for risk stratification.

Purpose of the Study:

• To identify pathological predictors for lymph node metastasis in patients with T1 colorectal cancer.
• To evaluate the predictive value of specific pathological features including differentiation, invasion depth, lymphatic/venous invasion, and tumor budding.

Main Methods:

• A retrospective review of 164 patients with single T1 colorectal cancer who underwent surgery.
• Analysis of pathological features: non-well differentiation, invasion depth (>= 2000 microm), lymphatic channel involvement, venous invasion, and tumor budding.
• Logistic regression modeling was used to assess predictor significance for lymph node metastasis.

Main Results:

• Lymph node metastasis was present in 9.8% of patients.
• Non-well differentiation (13.4%) and tumor budding (14.6%) showed higher positive rates.
• Multivariate analysis identified non-well differentiation (P < 0.001) and tumor budding (P = 0.002) as significant predictors.
• A model combining these two factors achieved 94% sensitivity and 82% specificity for predicting lymph node metastasis.

Conclusions:

• Non-well differentiation and tumor budding are significant pathological predictors of lymph node metastasis in T1 colorectal cancer.
• These factors can aid in the accurate risk stratification of patients with early-stage colorectal cancer.
• The findings support the use of these pathological features in clinical decision-making for T1 colorectal cancer management.